17 alpha-hydroxyprogesterone caproate has been researched along with Obesity in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caritis, SN; Hauspurg, A; Lemon, LS; Serra, AE; Sharma, S; Venkataramanan, R | 1 |
| Egerman, R; Istwan, N; Ramsey, R; Rhea, D; Stanziano, G | 1 |
| Co, AL; Hade, EM; Iams, JD; Walker, HC | 1 |
| Allshouse, AA; Carey, JC; Heyborne, KD | 1 |
| Dearmond, C; Henderson, ZT; How, H; Sibai, B; Wolfe, K | 1 |
| Boyle, A; Driggers, RW; Feghali, M; Istwan, N; Rhea, D; Timofeev, J | 1 |
2 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Obesity
| Article | Year |
|---|---|
Impact of Obesity on the Rate of Recurrent Spontaneous Preterm Birth in Women Treated with 17-alpha Hydroxyprogesterone Caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Body Mass Index; Female; Gestational Age; Humans; Logistic Models; Obesity; Pregnancy; Premature Birth; Progestins; Recurrence; Young Adult | 2018 |
Does 17-alpha hydroxyprogesterone caproate prevent recurrent preterm birth in obese women?
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Body Mass Index; Female; Gestational Age; Humans; Hydroxyprogesterones; Obesity; Pregnancy; Premature Birth; Progesterone Congeners; Recurrence | 2015 |
4 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Obesity
| Article | Year |
|---|---|
Maternal characteristics influencing the development of gestational diabetes in obese women receiving 17-alpha-hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Body Mass Index; Diabetes, Gestational; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Maternal Age; Obesity; Pregnancy; Premature Birth; Retrospective Studies; Risk Factors; Tocolytic Agents; United States | 2014 |
Relation of body mass index to frequency of recurrent preterm birth in women treated with 17-alpha hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adolescent; Adult; Body Mass Index; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Hydroxyprogesterones; Obesity; Overweight; Pregnancy; Pregnancy Complications; Premature Birth; Progestins; Recurrence; Retrospective Studies; Young Adult | 2015 |
The rates of abnormal glucose challenge tests and gestational diabetes in women receiving 17α-hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Blood Glucose; Diabetes, Gestational; Dose-Response Relationship, Drug; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hydroxyprogesterones; Logistic Models; Obesity; Pregnancy; Premature Birth; Progestins; Prospective Studies; Secondary Prevention; Young Adult | 2011 |
Rates of recurrent preterm birth by maternal body habitus in women receiving 17α-hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Body Mass Index; Cohort Studies; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Obesity; Pregnancy; Pregnancy Complications; Premature Birth; Progesterone Congeners; Recurrence; Retrospective Studies; Young Adult | 2013 |